STEP-1 extension showed semaglutide patients regained two-thirds of their lost weight within a year of stopping, and cardiometabolic improvements largely reversed
Several large clinical trials have demonstrated that GLP-1 receptor agonists can reduce the risk of cardiovascular events, such as heart attacks and strokes, in people with type 2 diabetes who are at high risk for heart disease
Following FDA clearance of its IND application, the randomized, double-blind, single ascending dose study will evaluate the safety, tolerability, and body weight changes in healthy adults with a BMI of 30 or greater
Mi bn c bi vit di y gii p thc mc trn
The extracellular fibril matrix is composed of decondensed chromatin
Doctors must be careful with their math to keep patients safe